Clinical Pharmacology
Your medication, reviewed by a specialist
Medication reviews, second opinions and pharmacogenetic testing by a specialist in Clinical Pharmacology and Toxicology FMH. Reimbursed in Switzerland, available worldwide.
-
Reimbursed in Switzerland -
Worldwide
Services
What we do
Medication review
Comprehensive review of complex medication regimens for interactions, dosing and therapeutic duplication.
Drug interactions and adverse effects
Specialist assessment of clinically relevant interactions and adverse drug reactions.
Second opinion
Independent specialist opinion on a drug therapy, for patients and treating physicians.
Pharmacogenetics
Indication, ordering and interpretation of pharmacogenetic tests.
Pharmacogenetics
Indications for pharmacogenetic testing
- Unexpected or severe adverse drug reactions
- Before a therapy whose efficacy or tolerability depends on the genotype
- Lack of efficacy despite correct use
- Unusually high dose requirements
Send us existing genetic test results, medical records, laboratory results and the current medication. We interpret existing pharmacogenetic results or assess whether a test is eligible for reimbursement in Switzerland.
Reimbursement in Switzerland
Basic health insurance covers pharmacogenetic testing subject to the following limitations:
- Only before a medicine is administered, or after an adverse reaction or lack of efficacy with a scientifically established link to the genes tested.
- Not for the diagnosis of disease, predisposition testing, or HLA typing without a drug-related indication.
- For the five drug and gene pairs on the SGKPT list, any physician may order the test.
- For all other medicines, testing may only be ordered by specialists in Clinical Pharmacology and Toxicology.
The SGKPT list
Physicians and pharmacists may order pharmacogenetic tests under their own professional responsibility (GUMV Art. 5 and 7).
Legal basis
Relevant documents in Switzerland
PDF, in German as published.
-
Analysenliste FOPH, Annex 3 to the KLV · 1 July 2025 -
KLV, Health Insurance Benefits Ordinance SR 832.112.31 · 1 July 2025 -
GUMG, Federal Act on Genetic Testing in Humans SR 810.12 · 1 August 2025 -
GUMV, Ordinance on Genetic Testing in Humans SR 810.122.1 · 3 March 2023 -
SGKPT list of common pharmacogenetic tests Version 3.0 · 11 July 2019